MVision develops technology that improves the treatment of various types of cancer by using artificial intelligence and machine learning. The company has been built on the idea to be an impactful organisation by bringing AI assisted diagnosis and treatment to whoever needs it, especially in developing countries. This dramatically improves treatment outcome and saves money. The founding team consists of AI PhD’s, data platform architects and physicists with experience from companies such as Varian Medical Systems and GE healthcare. MVision AI is a mission-oriented startup helping clinicians to save lives. MVision AI specializes in the field of medical imaging and artificial intelligence. MVision’s new artificial intelligence (AI) contouring software uses cutting-edge, deep learning technology to help you reduce manual contouring work and save treatment planning time. Our cloud-based AI model seamlessly integrates with hospital systems to provide consistent and reliable contours of critical structures.
Total Funding: $2.4 M
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2G, B2B
Company Size: 26 to 50
Founded: 2017
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at MVision AI
